NURS FPX 6011 Assessment 3 Implementing Evidence-Based Practice

NURS FPX 6011 Assessment 3 Implementing Evidence-Based Practice

Student Name

Capella University

NURS-FPX6011 Evidence-Based Practice for Patient-Centered Care and Population Health

Professor Name

Submission Date

 

Implementing Evidence-Based Practice

In healthcare, evidence-based practice framework that combines practitioner expertise, patient values, and current research to guide clinical decisions. Internal Data shown that many of patient’s visit their doctor with physical complaints while they have underlying mental health issues which go unaddressed. The longer it takes to identify these mental health issues the worse the symptoms will be and the lower the quality of life for the patient. systematized methods of identifying patients who may have mental illness such as systematic screening and collaborative care model, implementing them routinely on a consistent basis. Therefore, this plan establishes, evidence-based research and implement that into practice to reduce the burden of mental illness through earlier detection and coordination of services within primary care using standardized tools verses just routine screenings.

Background information on the clinical problem

Depression is a major clinical issue affecting Black Americans mood, thought, and functioning which results in lower quality of life, increased health service utilization, and greater suicide risk. There are estimated to be over 280 million individuals who have been affected by depressive disorder world-wide thus making them one of the top causes of disability on a global basis, contributing substantially to years lived with disability (Santomauro et al., 2021). Further, there is strong evidence from systematic reviews conducted using data collected through primary care settings indicating that about 20% or one in five patients seen at primary care clinics experience some level of clinically relevant depressive symptomology and therefore remain undiagnosed without routine screening (Fekadu et al., 2022). The need for practice change arises due to the fact that most existing healthcare systems do not provide consistently applied screening, early detection methods, nor comprehensive treatments for depression, all of which contribute to delays in receiving appropriate care and subsequently poor patient outcomes.

PICOT Question

“Among Black American adults (P), how does the implementation of routine depression screening using the PHQ-9 tool (I) compare to usual care without standardized screening (C) in affecting the rates of early identification and referral for depression and anxiety (O) within a 3-month period (T)?”

P (Population): Black American patients

I (intervention): how does routine depression screening using the Patient Health Questionnaire – 9 (PHQ-9) tool

C (Comparison): compared to usual care without standardized screening

O (Outcome): improvement with early identification and referral for depression and anxiety

T (Time): intervention duration is 3 months (12 weeks)

Action plan for implementation

The implementation timeline for Black Americans with depression recommendation is expected about 3 months. In the first 2 weeks the Project Team will have completed stakeholder meetings and communications, staff education/training, and assess existing screening practices for a Baseline Assessment (Ward et al., 2021). During weeks 3-5 the project team will implement changes to the work flow that include integrating PHQ-9 into the electronic health record (EHR), developing standardized referral processes. Weeks 6-10 are designated as the Pilot Phase during which time all eligible adult patients will receive a PHQ-9 screen, while continuously tracking completion rates, positives and referrals. Weeks 11-12 are designated as evaluation of outcomes, staff feedback collection & refining the process for full-scale implementation.

  • Tools and Resources

Intervention requires substantial resources including funding grants, trained healthcare staff, and mobile health technology platforms. The tools necessary to successfully implement intervention include a PHQ-9 Screening integrated with the EHR; clinical guidelines for interpreting results and clear pathways for behavioral health services. Combining other Complementary Tools may greatly increase accuracy, speed and concentration in Primary Care Settings (Cronkleton, 2023). Collectively, these tools provide alternatives for differing clinical situations, severity tracking, population specific screening, and comprehensive Mental Health Assessments resulting in improved overall detection and treatment of Depressive Disorders in Primary Care.

Stakeholders Identification

The stakeholders in intervention included psychologists, psychiatrists, nurse practitioner, physician assistant’s patients and their family. Psychologists’ health professionals are able to provide a diagnosis and treatment for clients based on referrals, nurses and medical assistants assist in administering screening, clinicians and administrative staff coordinate the workflow and allocate resources. Community organizations and faith leaders will partner in implementation and outreach efforts (Rosenthal et al., 2022).

  • Opportunities for Innovation

 Developing opportunity for new innovations could be integrating the PHQ-9 into EHRs, so it can automatically score the client, and provide the practitioner with clinical decision support (Johnson & Stead, 2022). Another opportunity is utilizing Patient Portals/Digital Pre-Visit Screening. This would allow the practitioner to receive the results prior to the appointment, thereby reducing their work-load during the visit. Collaborative Care Models could also be developed. These types of innovations help increase detection and referral rates by streamlining processes, increasing efficiencies, and decreasing time required to identify potential cases of depression in primary care clinics.

  • Potential Barriers and Action

Several barriers may hinder the successful implementation of routine PHQ-9 screenings for depression. Key barrier to the successful implementation of routine PHQ-9 screenings for depression in primary care consist of limited consultation times with providers, lack of adequate education/training of staff, providers, lack of willingness by providers to make workflow adjustments, lack of access to mental health services, including but not limited to psychologists, technological limitations with electronic health records (EHR) systems and reluctance on the part of patients to report their symptoms (Blake, 2022). In order to successfully implement and sustain the use of routine PHQ-9 screenings for depression in primary care it will be important to provide education, training to staff and providers to develop methods for integrating workflow and improve access to mental health services.

Outcomes Criteria

Effectiveness evaluation of the PHQ-9 screening project is the process of evaluating the success of this project will begin with a collection of baseline information regarding what is currently done at the clinic to screen for depression, rate at which mental health referrals are made from the clinic, how long it takes to complete a mental health referral, and if there is an existing trend or pattern of PHQ-9 documentation occurring in the clinic. Following the implementation of this project’s new procedures, outcomes of the project will be evaluated as follows: A) Increase in number of PHQ-9 screens completed; B) Number of screens resulting in a diagnosis of depression; C) Rate at which referrals for mental health services are initiated and completed within three months after the initial assessment; D) Reductions in symptoms associated with depression utilizing repeated PHQ-9 screenings documented via the electronic health records (Korsen & Gerrish, 2022).

  • Alignment with Quadruple Aim

All of these outcomes support one of the four quadruple aims established by specify: clinical outcomes, quality-through early detection and treatment, patient experience-timely access to mental health care, provider satisfaction-standards based workflows, reducing uncertainty when identifying depression, and cost-savings through prevention of complications due to untreated depression (Ales et al., 2026). The US Preventive Services Task Force evidence that standardized depression screening practices within a primary care setting enhance the ability to identify depression and provide connections to care as opposed to unstructured methods of identifying depression (US Preventive Services Task Force, 2023). Collectively, all the above-mentioned evaluation metrics will assist in assessing the degree of influence on the practice change implemented by this project and also help inform future revisions to the clinic’s depression screening policies and primary care guidelines.

  • Evidence-Based Practice Impact

The impact of evidence-based practice (EBP) using standardized PHQ-9 screenings ensure the delivery evidence-based clinical results consistent with the Quadruple Aim’s focus on delivering high-quality and care. EBP framework in a clinical setting provides for the enhancement of clinical quality through early detection of mental illness and also increases the patient experience due to increased access to appropriate referral services for mental health issues (Melnyk & Fineout-Overholt, 2023). A systems approach to workflow will decrease diagnostic confusion and reduce administrative time burden which should lead to improved job satisfaction among providers and better operational performance (Ales et al., 2026). The overall impact of using evidenced based approaches as part of this project should provide substantial financial benefits through reduced costs associated with treating patients who develop complications from untreated depression; thus, creating alignment between current clinical research findings and clinical practices in the primary care setting.

Value and Relevance

A large number of peer reviewed studies that have been published between 2022 and 2026 were identified through a broad electronic search using the three major databases; PubMed, MEDLINE, and Google Scholar. The search terms for the study included PHQ-9, depression screening, primary care, mental health referrals, and evidence-based practices. As with all reviews, inclusion criteria included the population being an adult population receiving primary care services, routine depression screening occurring as part of their primary care visit, and whether studies examined implementation strategies and/or outcomes related to referrals due to depression. All other types of studies and non-peer reviewed publications were removed from consideration.

Conclusion

Depression is a common but frequently underdiagnosed condition that contributes to worsened health status, enhanced levels of healthcare utilization, and lowered quality of life in Black American patients. The current body of research provides strong evidence supporting the effectiveness of routinely using the PHQ-9 as a tool for improving early recognition of depression and providing efficient referral to mental health services. Routine screening using the PHQ-9 can lead to improved detection rates by utilizing structured work flows and facilitating collaboration among stakeholders; also, it will provide easier access to mental health services. This EBP has the potential to positively influence patient outcomes, increase provider efficiency, and ultimately create a better environment for delivering high-quality care in the primary care arena.

Step-By-Step Instructions to write
NURS FPX 6011 Assessment 3

Contact us today and receive expert step-by-step instructions for NURS FPX 6011 Assessment 3.

References for
NURS FPX 6011 Assessment 3

Ales, M., Dowrick, C., Ariba, A., Mugambi, J., Tavares, A. L. B., Kassai, R., Lionis, C., & Rodrigues, S. (2026). Implementing systematic depression screening in primary care: lessons from the MDD minds global quality improvement pilot. BioMed Central Primary Care27(1)(101). https://doi.org/10.1186/s12875-026-03213-9

Blake, C. (2022). Depression screening implementation: quality improvement project in a primary care clinic for first responders. Workplace Health & Safety70(12), 216507992211191. https://doi.org/10.1177/21650799221119147

Bruni, T., Smith, S., Quigley, J., Koval, E., LaLonde, L., Maragakis, A., Kilbourne, A. M., King, C., Orringer, K., & Lee, J. M. (2024). Real-world depression screening practices among primary care providers across patient-level and provider-level characteristics. Clinical Pediatrics63(10), 1442–1451. https://doi.org/10.1177/00099228231223782

Cronkleton, E. (2023). Depression screening tools: PHQ, BDI, CES-D, EQ-5D, and more. Www.medicalnewstoday.com. https://www.medicalnewstoday.com/articles/depression-screening-tools

Fekadu, A., Demissie, M., Birhane, R., Medhin, G., Bitew, T., Hailemariam, M., Minaye, A., Habtamu, K., Milkias, B., Petersen, I., Patel, V., Cleare, A. J., Mayston, R., Thornicroft, G., Alem, A., Hanlon, C., & Prince, M. (2022). Under detection of depression in primary care settings in low and middle-income countries: a systematic review and meta-analysis. Systematic Reviews11(1). https://doi.org/10.1186/s13643-022-01893-9

Johnson, K. B., & Stead, W. W. (2022). Making electronic health records both SAFER and SMARTER. JAMA328(6). https://doi.org/10.1001/jama.2022.12243

Korsen, N., & Gerrish, S. (2022). Use of PHQ-9 for monitoring patients with depression in integrated primary care practices. The Annals of Family Medicine20(Supplement 1). https://doi.org/10.1370/afm.20.s1.2769

Melnyk, B. M., & Fineout-Overhold, E. (2023). Evidence-based practice in nursing & healthcare (5th ed.). Lippincott Williams & Wilkins.

Rosenthal, A. E., Spezia, M., Sosnowy, C., & Chan, P. A. (2022). Acceptability of HIV prevention approaches among USA faith-based leaders. Journal of Religion and Health62(3), 1658–1675. https://doi.org/10.1007/s10943-022-01705-3

Santomauro, D. F., Herrera, A. M. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., Bang-Jensen, B. L., Bertolacci, G. J., Bloom, S. S., Castellano, R., Castro, E., Chakrabarti, S., Chattopadhyay, J., Cogen, R. M., Collins, J. K., & Dai, X. (2021). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 Pandemic. The Lancet398(10312), 1700–1712. https://doi.org/10.1016/S0140-6736(21)02143-7

US Preventive Services Task Force. (2023). Screening for depression and suicide risk in adults: US preventive services task force recommendation statement. JAMA329(23), 2057–2067. https://doi.org/10.1001/jama.2023.9297

Ward, E. C., Brown, R. L., Sullivan-Wade, L., & Sainvilmar, S. (2021). A culturally adapted depression intervention for African American Adults: An efficacy trial. WMJ : Official Publication of the State Medical Society of Wisconsin120(4), 273. https://pmc.ncbi.nlm.nih.gov/articles/PMC9815899/

Best Capella professors to choose from for
NURS-FPX6011 Class

  • Buddy Wiltcher, EdD, MSN, APRN, FNP-C
  • Lisa Kreeger, PhD, RN

(FAQs) related to
NURS FPX 6011 Assessment 3

Question 1: What is NURS FPX 6011 Assessment 3 about?

Answer 1: NURS FPX 6011 Assessment 3 implements PHQ-9 depression screening for Black American primary care patients.

Scroll to Top